A Look At ResMed (RMD) Valuation After Earnings Beat And Strong Start To Fiscal 2026

ResMed (RMD) shares recently moved after an earnings report that showed a beat on EPS estimates while revenue matched expectations. Management described fiscal 2026 as off to a strong start. See our ...

Should ResMed's (RMD) Earnings Beat and Margin Gains Require Action From Investors?

In its recent past quarterly update, ResMed reported US$1.34 billion in revenue, growing around 9% year on year, with earnings per share ahead of analyst expectations while revenue aligned with ...
StockStory.org on MSN

Reflecting on patient monitoring stocks’ Q3 earnings: ResMed (NYSE:RMD)

With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...
Reuters

ResMed slightly beats quarterly profit estimates, shrugs tariff concerns

April 23 (Reuters) - Resmed (RMD.N), opens new tab beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep ...